Completed NA INTERVENTIONAL 2-arm NCT04329000

On-demand PPI Therapy is Effective on Controlling Symptoms in Patients With Barrett's Esophagus.

The Impacts of On-demand Versus Continuous Esomeprazole Therapy on the Symptom Control and Histological Changes of Metaplastic Esophageal Epithelium in Patients With Barrett's Esophagus (EsoBE) - a Multicentre Randomized Controlled Trial

Sponsor: Kaohsiung Veterans General Hospital.

Conditions Barrett Esophagus Proton Pump Inhibitor Reflux Symptom

Interventions Esomeprazole Esomeprazole 40mg

Updated 5 times since 2020 Last updated: Apr 1, 2020 Started: Feb 2, 2010 Primary completion: Feb 13, 2019 Completion: Dec 8, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Barrett Esophagus and Proton Pump Inhibitor and is currently completed. Kaohsiung Veterans General Hospital. leads this study, which shows 5 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Sep 2020 — Jan 2021 [monthly]

Completed NA
May 2020 — Sep 2020 [monthly]

Completed NA

First recorded

Feb 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Kaohsiung Veterans General Hospital.

Data source: Kaohsiung Veterans General Hospital.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.